Argos Therapeutics (FRA:77AA) Ending Cash Position : €6.81 Mil (As of Sep. 2018)

View and export this data going back to 2014. Start your Free Trial

What is Argos Therapeutics Ending Cash Position?

Argos Therapeutics's Ending Cash Position for the quarter that ended in Sep. 2018 was €6.81 Mil.

Argos Therapeutics's quarterly Ending Cash Position declined from Mar. 2018 (€13.80 Mil) to Jun. 2018 (€10.38 Mil) and declined from Jun. 2018 (€10.38 Mil) to Sep. 2018 (€6.81 Mil).

Argos Therapeutics's annual Ending Cash Position increased from Dec. 2015 (€5.66 Mil) to Dec. 2016 (€50.22 Mil) but then declined from Dec. 2016 (€50.22 Mil) to Dec. 2017 (€12.84 Mil).

Argos Therapeutics Ending Cash Position Historical Data

The historical data trend for Argos Therapeutics's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Argos Therapeutics Ending Cash Position Chart

Argos Therapeutics Annual Data

Trend

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Ending Cash Position

Get a 7-Day Free Trial

24.31

30.19

5.66

50.22

12.84

Argos Therapeutics Quarterly Data
	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18
Ending Cash Position	Get a 7-Day Free Trial															8.49	12.84	13.80	10.38	6.81

Argos Therapeutics Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Argos Therapeutics's Ending Cash Position for the fiscal year that ended in Dec. 2017 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	44.763	+	-31.928
	=	12.84

Argos Therapeutics's Ending Cash Position for the quarter that ended in Sep. 2018 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	10.392	+	-3.587
	=	6.81

Argos Therapeutics Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Argos Therapeutics's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Argos Therapeutics (FRA:77AA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Argos Therapeutics Inc (FRA:77AA) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

4233 Technology Drive, Durham, NC, USA, 27704

Website

http://www.argostherapeutics.com

Argos Therapeutics Inc is a biopharmaceutical company. It is engaged in the development and commercialization of immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis.

Argos Therapeutics (FRA:77AA) Headlines

No Headlines